Guidance released for $1 billion in tax credits
This article was originally published in The Gray Sheet
Executive Summary
Beginning June 21, qualifying companies with 250 or fewer employees may apply for the new Therapeutic Discovery Project Program tax credit, assuming their projects "show a reasonable potential" to address unmet medical needs, reduce health care costs or advance cancer research. The application period runs through July 21, 2010. HHS will evaluate applications and the IRS will issue certifications no later than Oct. 29, 2010. Individual tax credits of up to $5 million are available per qualifying firm to cover up to 50% of the cost of qualifying biomedical research in 2009 and 2010. Firms can opt for a grant instead. The Treasury Department and National Institutes of Health jointly announced the 1guidelines on May 21. Authorization for the tax credit was included in the recent health reform law
You may also be interested in...
Health Reform Delivers Cash, Credits To 3,000 Small Health Tech Firms
Nearly 3,000 U.S. health care technology companies will receive the first round of federal grant or tax credit awards under a provision of the Affordable Care Act, federal officials announced Nov. 3.
Diagnostics Firms Poised To Gain From Innovation Tax Credit Program
Diagnostics firms stand to benefit most among medical device companies from $1 billion in life sciences innovation tax credits approved earlier this year, according to AdvaMed
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.